KOVAI6,350.00

Kovai Medical Center & Hospital Limited

· Pharma & Health
₹ CrorePeersDRAGARWQKMCSHILLOTUSEYEGPTHEALTHGKSLSHALBYINDRAMEDCOARTEMISMED
Comp Set
In ₹ Crore except Per Share
Latest Annual
KOVAI
FY20
DRAGARWQ
FY26
KMCSHIL
FY24
LOTUSEYE
FY26
Peer
Median
Valuation — at last close
P/E73.46×36.06×74.09×2812.50×74.09× -1%
P/B3.89×3.89×
EV/EBITDA72.00×72.00×
Market Cap₹234 Cr₹234 Cr
Growth
Revenue CAGR 3Y20.68%19.96%4.52%19.96%
Revenue CAGR 5Y22.59%10.66%16.63%
Net Income CAGR 3Y23.83%33.46%-72.98%23.83%
Revenue YoY (latest Q)26.19%26.19%
Net Income YoY (latest Q)12.65%12.65%
Profitability
EBITDA Margin23.61%30.86%26.75%6.30%26.75% -12%
Net Income Margin13.29%14.89%17.15%0.15%14.89% -11%
Return on Common Equity21.94%20.24%0.13%10.18% +115%
Return on Capital Employed10.47%15.21%-0.50%7.36% +42%
Return on Assets8.54%9.15%0.10%4.63% +85%
Credit & Quality
Total Debt/Equity1.18×0.24×0.19×0.21× +449%
Interest Coverage7.93×8.39×32.79×-0.43×8.39× -5%
Scale — latest FY
Revenue / Total Income₹712 Cr₹471 Cr₹177 Cr₹53.7 Cr₹177 Cr +302%
Net Income₹94.6 Cr₹70.1 Cr₹30.4 Cr₹0.1 Cr₹30.4 Cr +211%
Total Assets₹1,107 Cr₹766 Cr₹82.6 Cr₹425 Cr +161%
EPS₹86.44₹147.02₹1.86₹0.04₹1.86 +4547%
Book Value per Share₹28.92₹28.92
◆ best value in the comp set per metric · Δ = subject vs median of the other companies.
« ‹ › »Latest: FY20 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 85%.